melanotan 2 pathways Benefits of Melanotan-II (MT-2) melanotan ii autism study MARK2

Irisin was revealed to have neuroprotective effects on PD by activating the ERK, P38MAPK and AMPK pathways and then upregulating Nrf2, HO-1, and Bcl-2 independently of NF-B, reducing the release of cytokines and the NLRP3 inflammasome and Caspase-1 [87]

doi:10.1111/bcp.12362

Since most of the proteins coded by mtDNA are involved in ETC, mutations and deletions in mtDNA would likely disturb ETC and increase ROS formation, creating a vicious cycle further inflicting mitochondrial damage [46]

Jia Y, Cai S, Muhoza B, Qi B, Li Y

However, management decisions are often based on either expert opinion or retrospective data, rather than prospective trials

Daily routine: Morning: Topical GHK-Cu to scalp Evening: Topical GHK-Cu to scalp Every day: BPC-157 500mcg subcutaneous injection 3x per week: TB-500 2-5mg subcutaneous injection (maintenance dose) Bedtime: IGF-1 LR3 50-60mcg (4-6 week cycles with breaks) Additional: Weekly microneedling with GHK-Cu application immediately after Monthly progress photos and measurements Expected results: This is the most aggressive protocol